BioScrip Inc. (BIOS) announced that it has signed a definitive agreement to acquire Critical Homecare Solutions, a provider of home infusion and home health agency services to patients suffering from chronic and acute medical conditions.
BioScrip will acquire Critical Homecare Solutions for a total of $343.2 million in cash and stock. The consideration will include cash of $242.0 million, including approximately $132.0 million to repay Critical Homecare Solutions' debt, and the issuance of $101.2 million of common stock, or approximately 12.94 million shares. BioScrip will also issue 3.40 million warrants with a $10.00 exercise price and five-year term to Critical Homecare shareholders.
BioScrip said Jefferies Finance LLC has provided a $375 million financing commitment, including a $50 million revolving credit facility, which is expected to be substantially unfunded at close of the transaction. The transaction is expected to be financed through a combination of bank financing and the issuance of senior notes. The transaction is expected to close by March 31.
BioScrip stated that, assuming a closing date of March 31, 2010 financial results would include 9 months of Critical Homecare Solutions' operations. BioScrip estimates that the combined company will generate revenues in 2010 of approximately $1.67 billion-$1.73 billion, gross profit of $267.0 million-$277.0 million, or approximately 16% percent of sales, and adjusted EBITDAO of $67.0 million-$71.0 million.
The company expects the transaction to be modestly accretive to earnings per share on a cash basis and slightly dilutive on a GAAP basis in 2010. Cash and GAAP earnings per share accretion is expected in 2011 and beyond.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.